-
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)
YOKOHAMA, Japan, June 24, 2026 /PRNewswire/ — REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds exclusive commercialization rights in Japan. The application seeks approval for the use of Stemchymal® to suppress the progression of ataxia in…
-
Fireaway Achieves Type Approval and EU/UK Marine Equipment Certification for Stat-X® Condensed Aerosol Fire-Extinguishing Systems Following MSC.1/Circ.1270 Evaluation
Three certificates issued by Bureau Veritas support application in SOLAS-regulated marine environments across global, EU-flagged, and UK-flagged vessels. MINNETONKA, Minn., June 9, 2026 /PRNewswire/ — Fireaway Inc. today announced that its Stat-X® condensed aerosol fire-extinguishing systems have received type approval from Bureau Veritas following evaluation in accordance with MSC.1/Circ.1270. Three certificates covering the global market,…
-
BBBS & Israel's Foresight Awarded USD 5 Million to Build & Commercialize Rugged Autonomous Drones for Hazardous Industrial Environments
Big Bang Boom Solutions Pvt. Ltd. (BBBS), a leading Indian DeepTech startup, today announced the formal approval of a $5 million joint research, development, and commercialization project with Israel-based Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX). The project, funded under the India-Israel Industrial R&D and Technological Innovation Fund (I4F), will focus on developing rugged…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
